Navigation Links
Gene Test May Help Predict Colon Cancer's Return
Date:2/17/2009

A marker in lymph nodes points to more persistent tumors, scientists say

TUESDAY, Feb. 17 (HealthDay News) -- A genetic test may better help survivors of colorectal cancer determine their risk of recurrence, a new study finds.

A report in the Feb. 18 issue of the Journal of the American Medical Association finds that guanylyl cyclase C (GUCY2C) -- an intestinal tumor-suppressing receptor in the lymph nodes -- may better reveal the chance of metastatic colorectal cancer.

According to researchers from Thomas Jefferson University in Philadelphia, doctors often biopsy the lymph nodes when trying to determine the prognosis of colorectal cancer. But when no cancer cells are found (a condition called pN0 colorectal cancer), the chance of recurrence is still about one in four. If cancer cells are found in four or more lymph nodes, the recurrence odds jump to one in two.

In studying 257 people with pN0 colorectal cancer, the team found that GUCY2C analysis "appeared to be an independent prognostic marker of risk." While conventional molecular staging techniques found 13 percent of patients were free of tumor cells, GUCY2C results suggested malignancy in 87 percent of cases.

Improved molecular staging "could overcome limitations in the detection of occult lymph node metastases," wrote the researchers.

The authors called for more studies with larger patient pools to better access the accuracy and reliably of the genetic test.

More information

The U.S. National Cancer Institute has more about colorectal cancer.



-- Kevin McKeever



SOURCE: Thomas Jefferson University, news release, Feb. 17, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Anti-social behavior in girls predicts adolescent depression seven years later
2. Urine Test May One Day Predict Prostate Cancer
3. Levels of Circulating Tumor Cells Could Predict Prostate Cancer Outcome
4. In Month of the Heart, Scientists Identify Better Way to Predict Heart-Disease Risk
5. MRI shows brain atrophy pattern that predicts Alzheimers
6. Gene Test Could Predict Thyroid Cancer Risk
7. Amyloid Beta Level in Serum Predicts Risk for Vascular Disease in First-Degree Relatives of Alzheimer's Patients
8. Protein predicts liver cancer recurrence and after transplantation
9. Rhythm abnormality of unknown origin strongly predicts sudden death risk in heart disease patients
10. Blood Test May Predict Postpartum Depression
11. Mental Illness Doesnt Predict Violent Behavior
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Test May Help Predict Colon Cancer's Return 
(Date:9/21/2017)... ... , ... SABRE is raising awareness about personal safety with a Chicago Transit ... , The Chicago, Illinois, based self-defense brand has been waiting for an opportunity like ... taking their personal safety into their own hands. , The ads focus on their ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device ... staying in compliance with FDA rules. , The FDA has issued two draft ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a ... public health departments have been awarded five-year accreditation status through the Public ... of being served by a PHAB-accredited health department now extend to more ...
(Date:9/21/2017)... ... ... In addition to sticking with the new years goal ... use natural alternatives for all house cleaning products, disinfectants, respiratory relief, and much ... new line of essential oils, are all 100% organic and natural. , Combine ...
(Date:9/21/2017)... ... September 21, 2017 , ... The New England Center for Children® (NECC®), a ... of Yie-Hsin Hung to the Board of Directors. , “The New England Center ... Hung is an invaluable addition to our team,” said Vincent Strully, Jr., President and ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/29/2017)... Aug. 29, 2017 ivWatch, LLC, the leading provider of ... announced it has been awarded an Innovative Technology contract from Vizient, ... country. ... to aid in the early detection of peripheral IV infiltration and ... The Innovative Technology contract was ...
(Date:8/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will present at the ... in New York . John Greisch ... present at 11:05 a.m. Eastern Time. The ... A recorded replay will be available one hour after the ... About Hill-Rom Holdings, Inc. ...
Breaking Medicine Technology: